European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations
United European Gastroenterology Journal · 2025-02 · 13 (1) · 125-172
DOI: 10.1002/ueg2.12674 ↗Kurz gefasst
Leitlinie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 05.12.2024. Verfasst von J Enrique Dominguez-Muñoz und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Exocrine Pancreatic Insufficiency, Enzyme Replacement Therapy, Gastroenterology. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 369 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: United European Gastroenterology.
Abstract (Originalsprache)
Pancreatic exocrine insufficiency (PEI) is defined as a reduction in pancreatic exocrine secretion below the level that allows the normal digestion of nutrients. Pancreatic disease and surgery are the main causes of PEI. However, other conditions and upper gastrointestinal surgery can also affect the digestive function of the pancreas. PEI can cause symptoms of nutritional malabsorption and deficiencies, which affect the quality of life and increase morbidity and mortality. These guidelines were developed following the United European Gastroenterology framework for the development of high‐quality clinical guidelines. After a systematic literature review, the evidence was evaluated according to the Oxford Center for Evidence‐Based Medicine and the Grading of Recommendations Assessment, Development, and Evaluation methodology, as appropriate. Statements and comments were developed by the working groups and voted on using the Delphi method. The diagnosis of PEI should be based on a global assessment of symptoms, nutritional status, and a pancreatic secretion test. Pancreatic enzyme replacement therapy (PERT), together with dietary advice and support, are the cornerstones of PEI therapy. PERT is indicated in patients with PEI that is secondary to pancreatic disease, pancreatic surgery, or other metabolic or gastroenterological conditions. Specific recommendations concerning the management of PEI under various clinical conditions are provided based on evidence and expert opinions. This evidence‐based guideline summarizes the prevalence, clinical impact, and general diagnostic and therapeutic approaches for PEI, as well as the specifics of PEI in different clinical conditions. Finally, the unmet needs for future research are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
- Department of Medicine, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Department of Gastroenterology, University Hospital Puerta de Hierro, Madrid, Spain.
- Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
- Department of Gastroenterology, San Raffaele University Hospital, Milan, Italy.
- Into-Sana Multi-Field Clinic, Odesa, Ukraine.
ORCID-Profile: J Enrique Dominguez-Muñoz, Miroslav Vujasinovic, Lukas Perkhofer, Stefanos Bonovas, J Matthias Löhr
Förderung
- United European Gastroenterology
Zitieren
APA
Dominguez-Muñoz, J. E., Vujasinovic, M., de la Iglesia, D., Cahen, D., Capurso, G., Gubergrits, N., Hegyi, P., Hungin, P., Ockenga, J., Paiella, S., Perkhofer, L., Rebours, V., Rosendahl, J., Salvia, R., Scheers, I., Szentesi, A., Bonovas, S., Piovani, D., Löhr, J. M., & European PEI Multidisciplinary Group (2025). European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations. United European Gastroenterology Journal, 13(1), 125-172. https://doi.org/10.1002/ueg2.12674
Vancouver
Dominguez-Muñoz JE, Vujasinovic M, de la Iglesia D, Cahen D, Capurso G, Gubergrits N, et al. European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations. United European Gastroenterology Journal. 2025;13(1):125-172. doi:10.1002/ueg2.12674
BibTeX
@article{DominguezMuoz2025,
author = {Dominguez-Muñoz, J Enrique and Vujasinovic, Miroslav and de la Iglesia, Daniel and Cahen, Djuna and Capurso, Gabriele and Gubergrits, Natalya and Hegyi, Peter and Hungin, Pali and Ockenga, Johann and Paiella, Salvatore and Perkhofer, Lukas and Rebours, Vinciane and Rosendahl, Jonas and Salvia, Roberto and Scheers, Isabelle and Szentesi, Andrea and Bonovas, Stefanos and Piovani, Daniele and Löhr, J Matthias and European PEI Multidisciplinary Group, European PEI Multidisciplinary Group},
title = {European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations},
journal = {United European Gastroenterology Journal},
year = {2025},
volume = {13},
number = {1},
pages = {125--172},
doi = {10.1002/ueg2.12674}
}
EUVIMED